Publication | Closed Access
Phase I and pharmacokinetic study of amrubicin, a synthetic 9-aminoanthracycline, in patients with refractory or relapsed lung cancer
30
Citations
14
References
2005
Year
OncologyPharmacologyPharmacokinetic StudySynthetic 9-AminoanthracyclineBronchial NeoplasmPharmacotherapyAnti-cancer AgentCancer TreatmentMedicineLung CancerCancer ResearchDrug Resistance
| Year | Citations | |
|---|---|---|
Page 1
Page 1